
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy in the frontline management of advanced and metastatic NSCLC
Jennifer Potash, Rachelle Laliberte, Paul M. Silverman, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 18, pp. S323-S332
Open Access | Times Cited: 6
Jennifer Potash, Rachelle Laliberte, Paul M. Silverman, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 18, pp. S323-S332
Open Access | Times Cited: 6
Showing 6 citing articles:
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases
Meng Zhang, Yong Fan, Ligong Nie, et al.
CHEST Journal (2022) Vol. 161, Iss. 6, pp. 1675-1686
Closed Access | Times Cited: 50
Meng Zhang, Yong Fan, Ligong Nie, et al.
CHEST Journal (2022) Vol. 161, Iss. 6, pp. 1675-1686
Closed Access | Times Cited: 50
Advancing the Boundaries of Immunotherapy in Lung Adenocarcinoma with Idiopathic Pulmonary Fibrosis by a Biomimetic Proteinoid Enabling Selective Endocytosis
Aimin Jiang, Xiaoqiang Zheng, Siqi Yan, et al.
ACS Nano (2024)
Open Access | Times Cited: 3
Aimin Jiang, Xiaoqiang Zheng, Siqi Yan, et al.
ACS Nano (2024)
Open Access | Times Cited: 3
The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
Ming-Yan Shi, Han-Ge Liu, Xiaohong Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Ming-Yan Shi, Han-Ge Liu, Xiaohong Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
Trang T. Vu, Kyeongmin Kim, Millennium Manna, et al.
Pharmacological Research (2023) Vol. 199, pp. 107048-107048
Open Access | Times Cited: 3
Trang T. Vu, Kyeongmin Kim, Millennium Manna, et al.
Pharmacological Research (2023) Vol. 199, pp. 107048-107048
Open Access | Times Cited: 3
Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology
Jeilene N. Hambly, Carl E. Ruby, Dan V. Mourich, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 5, pp. 336-336
Open Access | Times Cited: 2
Jeilene N. Hambly, Carl E. Ruby, Dan V. Mourich, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 5, pp. 336-336
Open Access | Times Cited: 2
Feasibility and Tolerability of Anlotinib Plus PD-1 Inhibitors for Previously-Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
Haili Wang, Shixia Zhou, Jing Kuang, et al.
Biologics (2024) Vol. Volume 18, pp. 313-326
Open Access
Haili Wang, Shixia Zhou, Jing Kuang, et al.
Biologics (2024) Vol. Volume 18, pp. 313-326
Open Access